{"id":1201468,"title":"DSEN Abstract: SGLT2 Inhibitors and the Risk of Major Adverse Cardiovascular Events - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-03-18","captureTimestamp":"2026-03-18T07:33:23.801000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/54002.html?wbdisable=false","snippet":"DSEN Abstract SGLT2 Inhibitors and the Risk of Major Adverse Cardiovascular Events A study conducted by the Canadian Network for Observational Drug Effect Studies (CNODES) SGLT2 inhibitor use was associated with a decreased risk of serious cardiovascular events compared with the…","rawSnapshotUrl":"/api/snapshots/raw/1201468","browseUrl":"https://replay.healtharchive.ca/job-8/20260318073323/https://cihr-irsc.gc.ca/e/54002.html?wbdisable=false#ha_snapshot=1201468","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}